Safecor Health to acquire UDL from Viatris to expand pharmaceutical unit-dose solutions
Safecor Health, a leader in pharmaceutical unit-dose repackaging and supply chain solutions, has announced its acquisition of the U.S. unit-dose packaging business of Viatris Inc., ... Read More
Sandoz and Biocon Biologics sign distribution deal for key immunology drug
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd and a prominent player in the global biosimilars market, has entered into a pivotal Distribution Agreement ... Read More
Biocon Biologics wraps up integration of Viatris’ biosimilars business in Europe
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced the successful completion of the integration of Viatris’ biosimilars business across 31 European countries. ... Read More
Viatris Inc. announces divestitures in key business sectors: Comprehensive breakdown
Viatris Inc. (NASDAQ: VTRS), a frontrunner in global healthcare, has unveiled a series of divestitures in its business framework. Leading the announcements, Viatris is set ... Read More
Biocon Biologics wraps up integration of former Viatris biosimilars business
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced the successful integration of the acquired biosimilars business from Viatris in over 70 countries ... Read More
Biocon Biologics debuts biosimilar HULIO in US market
In a significant development for healthcare accessibility, Biocon Biologics Ltd (BBL), a subsidiary of Biocon, announced the availability of its biosimilar injection, HULIO (adalimumab-fkjp), in ... Read More
Biocon Biologics wraps up $3.3bn acquisition of Viatris biosimilars unit
Biocon said that its subsidiary Biocon Biologics has wrapped up the previously announced $3.3 billion acquisition of the biosimilars business of US-based pharma company Viatris. ... Read More
Unichem Laboratories gets FDA approval for Dilantin generic
Unichem Laboratories Limited said that the US Food and Drug Administration (FDA) has approved its abbreviated new drug application (ANDA) for its Extended Phenytoin Sodium ... Read More
Biocon Biologics to buy biosimilars business of Viatris for up to $3.3bn
Biocon Biologics Limited (BBL), a subsidiary of Indian biopharma company Biocon, has agreed to acquire the biosimilars business of Viatris, a US-based pharma company, in ... Read More
Biocon Biologics, Viatris launch interchangeable biosimilars in US
Biocon Ltd. said that its subsidiary — Biocon Biologics and Viatris have launched interchangeable biosimilars SEMGLEE (insulin glargine-yfgn) injection, a branded product, and Insulin Glargine ... Read More